A drug to fight antibiotic resistance, a cancer-detecting test & more: 4 latest FDA approvals

Here are four drugs or medical devices that have been approved by the FDA since Sept. 28:

1. Libtayo is an injection for patients with metastatic cutaneous squamous cell carcinoma, the second most common skin cancer. It works by helping the body's immune system fight the cancer cells.

2. ClonoSEQ assay, a next generation sequencing test, detects very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma.

3. Insmed received approval for Arikayce for the treatment of a lung disease caused by a group of bacteria, Mycobacterium avium The treatment would be used as part of a combination regimen for adult patients who have limited or no alternative treatment options.

4. Nuzyra, a modernized tetracycline antibiotic, was approved for the treatment of community-acquired bacterial pneumonia and acute skin infections. It is an updated version of the antibiotic that can attack antibiotic-resistant strains.

More articles on supply chain:
FDA: Researchers who submit false clinical trials data might be fined
Amazon, Merck, Accenture to launch data-driven drug development platform
A preventive migraine treatment, surgical fluorescence & more: 4 latest FDA approvals

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 
 

Featured Webinars

Featured Whitepapers